Skip to main content

Table 5 Basic characteristics of participants after PSM Analysis

From: Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study

Outcomes

Normal (N = 1056)

COPD (N = 1056)

P

Age

61.646(0.441)

61.236(0.428)

0.455

Gender

  

0.932

 Male

608(53.177)

606(50.408)

 

 Female

446(46.823)

448(49.592)

 

Race

  

0.475

 Non-Hispanic White

774(85.919)

752(85.775)

 

 Non-Hispanic Black

158(7.076)

161(7.004)

 

 Mexican American

45(1.116)

55(1.192)

 

 Other

77(5.889)

86(6.028)

 

Education levels

  

0.570

 less than high school

142(8.248)

158(9.590)

 

 high school

210(16.928)

218(17.813)

 

 more than high school

702(74.824)

678(72.597)

 

PIR

  

0.920

 <1.85

522(37.614)

519(36.887)

 

 >=1.85

532(62.386)

535(63.113)

 

BMI group

  

0.288

 3<25

305(30.073)

331(31.726)

 

 >=25

749(69.927)

723(68.274)

 

Smoking status

  

0.501

 never

180(18.856)

159(16.795)

 

 former

526(46.477)

538(48.573)

 

 now

348(34.667)

357(34.632)

 

History of diabetes

  

0.984

 no

688(70.264)

684(71.949)

 

 IFG and IGT

91(7.078)

92(8.503)

 

 DM

275(22.657)

278(19.548)

 

History of hypertension

  

0.292

 no

344(41.030)

375(40.464)

 

 yes

710(58.970)

679(59.536)

 

CVD

  

0.936

 no

718(73.779)

716(72.769)

 

 yes

336(26.221)

338(27.231)

 

WBC

7.643(0.117)

7.585(0.092)

0.714

CRP

0.600(0.051)

0.605(0.044)

0.932

SII

537.889(386.105,760.769)

591.500(406.381,860.706)

0.002

  1. PSM, propensity score matching; COPD, Chronic Obstructive Pulmonary Disease; PIR, poverty income ratio; BMI, Body Mass Index; IFG, Impaired Fasting Glucose; IGT, Impaired Glucose Tolerance; DM, Diabetic Mellitus; CVD, Cardiovascular Disease; SII, Systemic Immune-Inflammation Index; WBC: White Blood Cell; CRP, C-reactive protein